Equity Analysis

Quarterly Results

    Jenburkt Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524731
    INE354A01013
    357.4658419
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    17.89
    542.04
    EPS(TTM)
    Face Value()
    Div & Yield %:
    68.66
    10
    1.24
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales41.2232.5438.84
Other Operating Income0.000.000.00
Other Income 1.851.411.19
Total Income43.0733.9440.03
Total Expenditure 29.7923.2528.99
PBIDT13.2810.7011.04
Interest 0.120.110.06
PBDT13.1610.5810.98
Depreciation0.640.520.62
Tax3.002.502.65
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.080.15-0.17
Reported Profit After Tax9.607.427.88
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item9.607.427.88
EPS (Unit Curr.)21.7516.8017.86
EPS (Adj) (Unit Curr.)21.7516.8017.86
Calculated EPS (Unit Curr.)21.7516.8017.86
Calculated EPS (Adj) (Unit Curr.)21.7516.8017.86
Calculated EPS (Ann.) (Unit Curr.)87.0167.2271.44
Calculated EPS (Adj) (Ann.) (Unit Curr.)87.0167.2271.44
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity4.414.414.41
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)32.2232.8828.42
PBDTM(%)31.9332.5128.27
PATM(%)23.2922.8020.29
Dividend Per Share(Rs)0.000.000.00
Diluted EPS21.7516.8017.86